July 18, 2009
from VoxRoxx Website
Baxter scientists patented the “swine
flu” vaccine two years before outbreak of “novel swine flu”
virus. Austrian Baxter scientist involved in H1N1 vaccine patent
also advises World Health Organization!
Otfried Kistner, the head of
virology at Baxter’s Austrian subsidiary in Orth an der Donau, which
contaminated 72 kilos of vaccine material with the live bird flu
virus and sent it to 16 labs this February, was part of the
Austrian-based Baxter team that applied for a provisional patent for
the “swine flu” H1N1 vaccine in August 2007, almost two years
before the first “swine flu” outbreak in Mexico City in
April2009 in a location about 50 kilometers from a Baxter facility.
Baxter’s Vaccine Patent Application US
2009/0060950 A1 gives “Kistner et al” as the applicant
for the patent for the H1N1 vaccine that was provisionally filed on
August 28, 2007.
Also Kistner is an advisor to
and took part in the WHO meeting in Geneva 2005 on the
Evaluation and Development of Influenza
It was WHO which supplied Baxter with the live bird flu virus that
Baxter used to contaminate 72 kilos of vaccine material, sending it
to 16 labs in four countries, nearly sparking a pandemic in
Baxter Files Swine Flu Vaccine Patent
a Year Ahead of Outbreak
by Lori Price
July 18, 2009
Barack Opharma issues the ultimate bad news during his weekly
Friday night bad news dump:
Legal immunity set for swine flu vaccine
makers 17 Jul 2009.
The last time the government embarked on
a major vaccine campaign against a new swine flu, thousands filed
claims contending they suffered side effects [paralysis, death] from
the shots. This time, the government has already taken steps to head
Vaccine makers and federal officials
will be immune from lawsuits that result from any new swine flu
vaccine, under a document signed by Secretary of Health and Human
Services Kathleen Sebelius, government health officials said
The document signed by Sebelius last
month grants immunity to those making a swine flu vaccine, under the
provisions of a 2006 law for public health emergencies.
Baxter Files Swine Flu Vaccine Patent a
Year Ahead of Outbreak
US20090060950A1 to Baxter
International filed 28th August 2008
10 Jul 2009
Patent Application US 2009/0060950 A1:
'In particular preferred
embodiments the composition or vaccine comprises more than
one antigen... such as influenza A and influenza B in
particular selected from of one or more,
of the human H1N1, H2N2,
H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes
of the pig flu H1N1, H1N2,
H3N1 and H3N2 subtypes
of the dog or horse flu
H7N7, H3N8 subtypes
of the avian H5N1, H7N2,
H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8,
H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes'
Baxter can take no more H1N1 flu vaccine
16 Jul 2009
While at least 50 governments have
placed orders or are negotiating with drug companies for
supplies of flu vaccine against the [their] fast spreading H1N1
strain, the lone U.S.-based maker has already taken on as much
as it can handle.
Baxter International Inc said on
Thursday it has taken orders from five countries, including
Britain, Ireland and New Zealand, for a total of 80 million
doses of H1N1 vaccine and will not take any more.
'Clearly we believe this demand
has the potential to translate into a significant
Baxter 2Q Profit Up 7.9%; Full-Year
16 Jul 2009
Baxter International Inc. posted a
stronger-than-expected 7.9% rise in second-quarter profit with
help from improved margins and product sales that continued to
avoid any hits from the economic downturn.
The medical-products maker boosted
its 2009 earnings guidance while saying the increase doesn't
reflect at this point any contribution from making a vaccine for
the H1N1 flu strain.
Baxter reported a second-quarter
profit of $587 million, or 96 cents a share, up from $544
million, or 85 cents a share, a year earlier.
Baxter working on vaccine to stop swine
flu, though admitted sending live pandemic flu viruses to
by Lori Price
26 Apr 2009
The OMFG moment of the century:
Illinois-based Baxter working on vaccine to 'stop' swine flu
outbreak in Mexico 25 Apr 2009 Specialty drug maker Baxter
International Inc. will work with the World Health Organization
to develop a vaccine that could stem [foment] an outbreak of a
deadly swine flu strain in Mexico.
Baxter spokesman Christopher Bona
said Saturday that the Deerfield, Ill.-based company has asked
for a sample of the flu strain.
He says Baxter has patented
technology that allows the company to develop vaccines in half
the time it usually takes - about 13 weeks instead of 26.
Baxter admits sending live avian flu
viruses to subcontractor
Baxter admits contaminated seasonal
flu product contained live bird flu virus 27 Feb 2009 The
company that released contaminated flu virus material from a
plant in Austria confirmed Friday that the experimental product
contained live H5N1 avian flu viruses.
And an official of the World Health
Organization's European operation said the body is closely
monitoring the investigation into the events that took place at
Baxter International's research facility in Orth-Donau, Austria.
Human trial of swine flu vaccine 'soon'
15 Jul 2009
The federal government has defended
its policy of not following the United Kingdom's lead and
rushing out a swine flu vaccine. Biopharmaceutical company CSL
will start clinical vaccine trials on 240 healthy adults in
Adelaide next week.
The vaccine is due to be rolled out